Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$3.02 - $4.56 $203,632 - $307,471
-67,428 Reduced 29.41%
161,841 $648,000
Q1 2022

May 16, 2022

BUY
$3.92 - $7.48 $439,588 - $838,807
112,140 Added 95.74%
229,269 $1.02 Million
Q4 2021

Feb 14, 2022

BUY
$6.7 - $11.38 $702,930 - $1.19 Million
104,915 Added 858.97%
117,129 $843,000
Q3 2021

Nov 15, 2021

BUY
$10.11 - $17.56 $123,483 - $214,477
12,214 New
12,214 $131,000

Others Institutions Holding ICAD

About ICAD INC


  • Ticker ICAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,333,900
  • Market Cap $30.1M
  • Description
  • iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...
More about ICAD
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.